GeneTether Therapeutics Inc. filed its Annual on Nov 04, 2021 for the period ending Dec 31, 2020. In this report its auditor, HORNE LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.045 CAD | -.--% | -.--% | +12.50% |
1st Jan change | Capi. | |
---|---|---|
+12.50% | 1.28M | |
+29.03% | 49.18B | |
-0.10% | 42.11B | |
+43.45% | 40.37B | |
-5.26% | 28.85B | |
+11.48% | 26.09B | |
-22.74% | 18.71B | |
+9.06% | 13.26B | |
+30.01% | 12.32B | |
-1.51% | 11.99B |
- Stock Market
- Equities
- GTTX Stock
- News GeneTether Therapeutics Inc.
- GeneTether Therapeutics Inc. Auditor Raises 'Going Concern' Doubt